Guillermo Barturen

Pts
Granada, AN, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 49 publications

Trans-eQTLs reveal the architecture of human gene regulatory networks.

Trans-eQTLs reveal the architecture of human gene regulatory networks.

Journal: medRxiv : the preprint server for health sciences

Published: April 29, 2026

Assessing the translational relevance of specific molecular pathways in spontaneous lupus mouse models.

Assessing the translational relevance of specific molecular pathways in spontaneous lupus mouse models.

Journal: Frontiers in immunology

Published: March 05, 2026

An Integrative Framework Identifies Cooperative Targeting of Host Pathways by Tick Salivary miRNAs.

An Integrative Framework Identifies Cooperative Targeting of Host Pathways by Tick Salivary miRNAs.

Journal: Computational and structural biotechnology journal

Published: January 30, 2026

Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren's disease.

Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren's disease.

Journal: Annals of the rheumatic diseases

Published: September 24, 2025

Untargeted breathomics identifies metabolic signatures of immune activity, intestinal integrity, and fatigue in systemic lupus erythematosus.

Untargeted breathomics identifies metabolic signatures of immune activity, intestinal integrity, and fatigue in systemic lupus erythematosus.

Journal: Annals of the rheumatic diseases

Published: July 08, 2025

Dysregulation of innate and adaptive lymphoid immunity may have implications for symptom attribution and predict responses to targeted therapies in neuropsychiatric systemic lupus erythematosus.

Dysregulation of innate and adaptive lymphoid immunity may have implications for symptom attribution and predict responses to targeted therapies in neuropsychiatric systemic lupus erythematosus.

Journal: Journal of translational autoimmunity

Published: March 21, 2025

Optimized network inference for immune diseased single cells.

Optimized network inference for immune diseased single cells.

Journal: Frontiers in immunology

Published: March 21, 2025

Differential molecular signatures in response to CD19-CAR T cell therapy compared with conventional pharmacotherapy in systemic lupus erythematosus.

Differential molecular signatures in response to CD19-CAR T cell therapy compared with conventional pharmacotherapy in systemic lupus erythematosus.

Journal: Annals of the rheumatic diseases

Published: February 16, 2025

Revisiting the heterogeneity of interferon-related autoimmune diseases.

Revisiting the heterogeneity of interferon-related autoimmune diseases.

Journal: Nature reviews. Rheumatology

Published: December 02, 2024

New IgG and IgA autoantibody specificities against DNA-binding and RNA-binding proteins discriminate systemic lupus erythematosus from health and non-lupus autoimmunity-could anti-LIN28A enhance precision in diagnostics?

New IgG and IgA autoantibody specificities against DNA-binding and RNA-binding proteins discriminate systemic lupus erythematosus from health and non-lupus autoimmunity-could anti-LIN28A enhance precision in diagnostics?

Journal: Annals of the rheumatic diseases

Published: November 27, 2024

Novel IgG and IgA autoantibodies validated in two independent cohorts are associated with disease activity and determine organ manifestations in systemic lupus erythematosus: implications for anti-LIN28A, anti-HMGN5, anti-IRF5, and anti-TGIF1.

Novel IgG and IgA autoantibodies validated in two independent cohorts are associated with disease activity and determine organ manifestations in systemic lupus erythematosus: implications for anti-LIN28A, anti-HMGN5, anti-IRF5, and anti-TGIF1.

Journal: Annals of the rheumatic diseases

Published: November 22, 2024

Identifying Predictive Biomarkers of Response in Patients With Rheumatoid Arthritis Treated With Adalimumab Using Machine Learning Analysis of Whole-Blood Transcriptomics Data.

Identifying Predictive Biomarkers of Response in Patients With Rheumatoid Arthritis Treated With Adalimumab Using Machine Learning Analysis of Whole-Blood Transcriptomics Data.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: September 30, 2024

Showing 1-12 of 49

Last Updated: 09/26/2026